J. Goldman & Co LP acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 631,951 shares of the company's stock, valued at approximately $25,057,000. J. Goldman & Co LP owned approximately 0.68% of Acadia Healthcare as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. FMR LLC boosted its position in Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the last quarter. Khrom Capital Management LLC acquired a new position in Acadia Healthcare during the fourth quarter valued at approximately $49,602,000. Balyasny Asset Management L.P. acquired a new position in Acadia Healthcare during the fourth quarter valued at approximately $43,092,000. Freestone Grove Partners LP acquired a new position in Acadia Healthcare during the fourth quarter valued at approximately $29,943,000. Finally, Magnetar Financial LLC lifted its position in shares of Acadia Healthcare by 385.4% in the fourth quarter. Magnetar Financial LLC now owns 928,772 shares of the company's stock valued at $36,826,000 after buying an additional 737,427 shares during the last quarter.
Acadia Healthcare Stock Performance
Shares of NASDAQ ACHC traded down $1.22 during trading hours on Wednesday, reaching $25.72. 2,813,643 shares of the stock were exchanged, compared to its average volume of 1,693,931. The firm has a market capitalization of $2.37 billion, a price-to-earnings ratio of 8.43, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The stock's fifty day simple moving average is $26.34 and its 200 day simple moving average is $36.01.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same quarter last year, the company earned $0.84 earnings per share. The firm's quarterly revenue was up .3% compared to the same quarter last year. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
Analyst Ratings Changes
A number of research firms have recently issued reports on ACHC. Barclays cut their price objective on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday. Mizuho cut their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday. Guggenheim began coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective for the company. Bank of America cut their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Finally, Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.
Check Out Our Latest Analysis on ACHC
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
